DMK PHARMACEUTICALS CORPORATION — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a5f5a5a1-ee64-4f22-baa0-37748f9baede/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2022 | $4.8M | 2022-01-01 – 2022-12-31 | evidence 0001387131-23-003523 |
| FY 2021 | $2.2M | 2021-01-01 – 2021-12-31 | evidence 0001387131-22-004483 |
| FY 2020 | $2.8M | 2020-01-01 – 2020-12-31 | evidence 0001387131-22-004483 |
| FY 2019 | $22.1M | 2019-01-01 – 2019-12-31 | evidence 0001387131-20-003438 |
| FY 2018 | $15.1M | 2018-01-01 – 2018-12-31 | evidence 0001387131-20-003438 |
| FY 2017 | $13.1M | 2017-01-01 – 2017-12-31 | evidence 0001387131-19-001966 |
| FY 2016 | $6.5M | 2016-01-01 – 2016-12-31 | evidence 0001387131-18-001080 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
DMK PHARMACEUTICALS CORPORATION — all facts · Net Income · Operating Income